+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blood Pressure Monitoring Market Report - United States - 2019-2025

  • ID: 4756762
  • Report
  • Region: United States
  • 503 pages
  • iData Research
1 of 3

FEATURED COMPANIES

  • A&D Medical
  • Citizen Systems
  • HoMedics
  • Medline
  • Panasonic
  • Qardio
  • MORE
The personal market is set to increase as more Americans adopt blood pressure monitoring practices. Both markets will continue to see an increase in digital sphygmomanometer sales, as aneroid kits are primarily purchased by medical schools, school boards, fitness professionals and some physician offices. Even then, the ease of use and attraction of digital devices is gaining popularity amongst the medical professional community.

Abnormal blood pressure levels are characterized by levels that are too high or too low. Hypertension refers to instances where an individual’s blood pressure is more elevated than “normal.” Hypotension refers to instances where the individual’s blood pressure is lower than “normal.” Both conditions may result in further health complications. For most individuals, healthy blood pressure ranges from 110/70 mmHg to 130/90 mmHg.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • A&D Medical
  • Citizen Systems
  • HoMedics
  • Medline
  • Panasonic
  • Qardio
  • MORE
1. Executive Summary
U.S. Patient Monitoring Equipment Market Overview
Competitive Analysis
Market Trends
Market Developments
Markets Included
Key Report Updates
Version History
Research Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. Blood Pressure Monitoring Market
2.1 Introduction
2.1.1 Aneroid Versus Digital Blood Pressure Monitoring
2.2 Market Overview
2.3 Market Analysis And Forecast
2.3.1 Total Personal Blood Pressure Monitoring Market
2.3.1.1 Digital Personal Blood Pressure Monitoring Market
2.3.1.2 Aneroid Personal Blood Pressure Monitoring Market
2.3.2 Total Professional Blood Pressure Monitoring Market
2.3.2.1 Digital Professional Blood Pressure Monitoring Market
2.3.2.2 Aneroid Professional Blood Pressure Monitoring Market
2.4 Drivers And Limiters
2.4.1 Market Drivers
2.4.2 Market Limiters
2.5 Competitive Market Share Analysis

3. Abbreviations

4. Appendix: Company Press Releases
4.1 Introduction
4.2 Press Releases
4.2.1 Draeger Medical
4.2.1.1 First half of 2018: Dräger increases net sales
4.2.1.2 New HealthTrust Agreement Covers Dräger’s Line of Anesthesia Solutions
4.2.1.3 Dräger and ICON Prepared to Support Hospitals with Ventilators During Times of Crisis
4.2.1.4 Dräger First to Achieve DIACAP Certification for Patient Monitoring and Clinical IT Systems
4.2.1.5 Dräger Infinity M300 Monitor Now Features FIPS Security
4.2.1.6 Dräger First to Achieve DIACAP Certification for Patient Monitoring and Clinical IT Systems
4.2.1.7 Dräger to Discuss Alarm Management and Strategies for Eliminating “Alarm Fatigue” at HIMSS16
4.2.2 Edwards Lifesciences
4.2.2.1 Edwards Lifesciences Reports Second Quarter Results
4.2.2.2 Edwards' Acumen Hypotension Prediction Index Launches In The U.S.
4.2.2.3 Edwards Lifesciences Reports Fourth Quarter Results
4.2.2.4 Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
4.2.2.5 Edwards Acquires Harpoon Medical
4.2.2.6 Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance
4.2.2.7 Edwards Lifesciences Reports Fourth Quarter Results
4.2.2.8 Edwards Lifesciences Completes Acquisition Of Valtech Cardio
4.2.2.9 Edwards Receives CE Mark For Hypotension Probability Indicator
4.2.2.10 Edwards Lifesciences Reports Second Quarter Results
4.2.2.11 Leslie Heisz Appointed To Edwards Lifesciences Board Of Directors
4.2.2.12 Edwards Lifesciences Reports First Quarter Results
4.2.2.13 Steven Loranger Appointed To Edwards Lifesciences Board Of Directors
4.2.2.14 Edwards Lifesciences Reports Fourth Quarter Results
4.2.3 Fukuda Denshi
4.2.3.1 Fukuda Denshi Introduces the UF-760AG Color Portable Ultrasound System in the U.S. A High Performance Color Portable Ultrasound Unit Designed for a Wide Array of Specialty Markets
4.2.3.2 Hospitals, Healthcare Providers to Save with the Fukuda Denshi USA Inc. and Amerinet Choice License and Supply Agreement
4.2.4 GE Healthcare
4.2.4.1 GE Healthcare Introduces Virtual Reality Training for Healthcare Technology Management Professionals
4.2.4.2 GE Healthcare and FitTrace announce collaboration to offer body composition analysis software for sports and fitness markets
4.2.4.3 GE Healthcare and Preventice Solutions Collaborate to Extend the Heart Station Beyond the Hospital
4.2.4.4 Veritas Capital to Acquire Revenue-Cycle, Ambulatory Care and Workforce Management Software Unit from GE Healthcare for $1 Billion
4.2.4.5 GE Healthcare, Ferozsons L.L. and P&SHD collaborate to deliver comprehensive training program for Maternal, Newborn & Child Health (MNCH)
4.2.4.6 Ministry of Health and GE delivering digital solutions to bring transformative change to Kingdom’s healthcare sector
4.2.4.7 GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment
4.2.4.8 Lifespan and GE Healthcare Put New Plan in Place to Reduce Care Delivery Costs by $182 Million over Six Years
4.2.4.9 GE Healthcare Receives Carequality Certification, Advancing Data Exchange with Cloud Technology
4.2.4.10 Catherine Estrampes appointed President & CEO of GE Healthcare Europe
4.2.4.11 GE Healthcare Acquires Novia Strategies to expand Clinical Consulting Capabilities and Help More Healthcare Organizations Achieve Breakthrough Outcomes
4.2.4.12 Emmanuel Ligner named President and CEO of GE Healthcare Life Sciences
4.2.4.13 GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration
4.2.4.14 Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery
4.2.4.15 Refurbished Parts for GE Diagnostic Imaging Equipment Now Available from GE Healthcare
4.2.4.16 Partners HealthCare and GE Healthcare launch 10-year collaboration to integrate Artificial Intelligence into every aspect of the patient journey
4.2.4.17 GE to help transform over 200 hospitals in Egypt with 700 units of its advanced healthcare technologies
4.2.4.18 GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare
4.2.4.19 Boston Children’s Hospital and GE Healthcare Working Together to Create Smart Imaging Technology to Better Detect Pediatric Brain Disorders
4.2.4.20 GE Healthcare showcases industry-first technologies and digital solutions, focused on improving outcomes, at RSNA 2016
4.2.4.21 GE Healthcare Taps Into $28 Billion Orphaned IP Market With Stake in Pilot Lite Ventures
4.2.4.22 UC San Francisco and GE Healthcare Launch Deep Learning Partnership to Advance Care Globally
4.2.4.23 Exploring digital solutions to combat heart disease
4.2.4.24 The OR Goes Digital: New Apps Drive Operational and Economic Outcomes
4.2.4.25 GE Healthcare opens USD 7.4 million APAC Fast Trak Bioprocessing Technology and Training Center in South Korea
4.2.4.26 See. Click. Send. New Cloud-based Ultrasound Solution Enables Instant, Enhanced Collaboration Among Clinicians
4.2.4.27 GE to invest €150 million in biopharmaceutical manufacturing campus in Cork, Ireland, and establish advanced manufacturing training centre at NIBRT
4.2.4.28 Boosting Compact Ultrasound IQ: GE Healthcare’s New Vivid™ iq Combines Power and Portability
4.2.4.29 GE Healthcare launches next generation Biacore(TM) molecular interaction analysis platform
4.2.4.30 GE Healthcare and Uppsala BIO form a new partnership
4.2.4.31 Charles Koontz Appointed President and CEO of GE Healthcare IT and GE Healthcare Chief Digital Officer
4.2.5 Honeywell Life Sciences
4.2.5.1 Honeywell Incorporates Integrated Video Capability Into Telehealth Platform Allowing Healthcare Professionals To Treat Patients In Their Homes
4.2.5.2 Honeywell Unveils New Version of FDA-Cleared Telehealth Software
4.2.5.3 Honeywell Presents Its Latest Connected Technologies That Help Reduce Clinical Errors At Saudi Health Exhibition
4.2.5.4 Honeywell Hosts Annual Investor Conference; Reaffirms First Quarter And Full-Year 2016 Outlook; Targets 2017 Core Organic Sales Up 4-5%
4.2.6 Masimo
4.2.6.1 New Study Investigates Impact of General Ward Clinical Monitoring Using Masimo Root®, Radius-7®, and Patient SafetyNet™ on Clinical Workflow and Patient Care
4.2.6.2 New Study Investigates the Utility of Masimo PVi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery
4.2.6.3 Masimo Announces Vital Signs Check Application for the Root® Patient Monitoring and Connectivity Platform
4.2.6.4 New Study Investigates the Utility of Masimo ORi™ (Oxygen Reserve Index) in Providing Early Detection of Blood Oxygenation Decrease During One-Lung Ventilation
4.2.6.5 United Arab Emirates Ministry of Health & Prevention Adopts National CCHD Newborn Screening Program Using Masimo Rad-97™ Pulse CO-Oximeters® with Eve™
4.2.6.6 Masimo and PositiveID Announce the U.S. Release of TIR-1™
4.2.6.7 New Study Investigates the Utility of Masimo SedLine® Patient State Index in Monitoring Anesthesia Depth of Patients with Healthy and Cirrhotic Livers
4.2.6.8 New Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb® for Reflecting Real-time Iatrogenic Hemodilution During Incremental Fluid Administration
4.2.6.9 Women's Tennis Association to Use Masimo MightySat™ Fingertip Pulse Oximeters to Advance Player Health and Performance
4.2.6.10 New Study Investigates the Economic Impact and Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb® in Reducing Unnecessary Blood Transfusions
4.2.6.11 Masimo SET® Pulse Oximetry Helps Form Basis of Utah Senate Resolution on Postoperative Oxygen Saturation Home Monitoring for Patients Prescribed Opioids
4.2.6.12 Masimo Reports First Quarter 2018 Financial Results
4.2.6.13 New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices
4.2.6.14 Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® with Integrated NomoLine™ Capnography
4.2.6.15 Masimo Announces UniView™
4.2.6.16 New Study Investigates the Performance of Masimo SpHb® During Acute Bleeding and After Fluid Resuscitation
4.2.6.17 Masimo Announces Replica™
4.2.6.18 Leading Nephrology Care Center in India Adopts Masimo Technologies Across Continuum of Care
4.2.6.19 New Study Evaluates the Performance of Masimo SpHb® in Monitoring Pediatric Trauma Patients
4.2.6.20 New Study Evaluates the Performance of Masimo PVi® as a Predictor of Fluid Responsiveness in Mechanically Ventilated ICU Patients
4.2.6.21 Masimo Announces CE Marking of Eve™ CCHD Newborn Screening Application for the Rad-97™ Pulse CO-Oximeter®
4.2.6.22 Masimo Announces FDA Clearance of Next Generation SedLine® Brain Function Monitoring
4.2.6.23 New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™, in Obese Patients
4.2.6.24 Masimo Announces FDA Clearance for Home Use of Rad-97™
4.2.6.25 Masimo Announces CE Marking and Release of Oxygen Reserve Index™ rainbow Lite Sensors
4.2.6.26 Artemis Hospital Becomes First in India to Adopt Masimo Patient SafetyNet™ Across All Hospital Care Areas
4.2.6.27 Masimo Announces FDA Clearance and Worldwide Release of NomoLine™ Capnography Sampling Lines
4.2.6.28 Masimo Supports World Pneumonia Day Efforts
4.2.6.29 Masimo Announces Distribution of Rad-57® Pulse CO-Oximeters® by The Jeffrey Lee Williams Foundation to First Responders
4.2.6.30 Masimo Announces U.S. Release of Trace™ Data Visualization and Reporting Tool
4.2.6.31 Masimo Announces Full Market Release of rainbow Acoustic Monitoring Sensor RAS-45
4.2.6.32 Masimo Announces FDA Clearance and Full Market Release of Rad-97™ Pulse CO-Oximeter®
4.2.6.33 Newborn Foundation and Masimo Partnership Reaches 52,000 Babies and 1,000 Health Workers through Newborn Screening Initiative in Support of Every Woman Every Child
4.2.6.34 Study Evaluates Performance of Masimo iSpO2® Rx Smart Device-Paired Pulse Oximeter in Screening Newborns for Critical Congenital Heart Disease
4.2.6.35 Study Evaluates Utility of Masimo SpHb® During High-Blood-Loss Oncosurgery
4.2.6.36 Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery
4.2.6.37 Dubai Health Authority Implements Masimo Patient SafetyNet™
4.2.6.38 Study Evaluates Performance of Masimo SpHb® in Trauma Patients with Low Hemoglobin Levels
4.2.6.39 Study Compares Performance of Masimo Acoustic Respiration Rate (RRa®) and Nellcor Plethysmographic Respiration Rate in Volunteers
4.2.6.40 Masimo Announces CE Marking of Noninvasive RPVi™, a rainbow® Multi-Wavelength Index of Pleth Variability
4.2.6.41 Masimo Announces CE Marking of rainbow® Super Sensor
4.2.6.42 New Study Compares Performance of Masimo Next Generation SedLine® Patient State Index (PSi) to Original PSi During Anesthesia
4.2.6.43 New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™
4.2.6.44 Masimo Announces Limited Market Release of Rad-67™ rainbow® Pulse CO-Oximeter® with Next Generation SpHb®
4.2.6.45 Masimo and Mdoloris Announce Masimo Open Connect™ (MOC) Partnership for the Root® Patient Monitoring and Connectivity Hub
4.2.6.46 Masimo Announces FDA 510(k) Clearance of O3™ Regional Oximetry for Pediatric Patients
4.2.6.47 Masimo Announces the Full Market Release of Early Warning Score (EWS) with the Root® Patient Monitoring and Connectivity Hub
4.2.6.48 Multicenter Study at UC Davis, UC Los Angeles, and Mayo Clinic Evaluates the Trend Accuracy of Masimo Continuous SpHb®
4.2.6.49 Masimo Introduces Rad-G™ Pulse Oximeter
4.2.6.50 Two Fire Rescue Departments Honored for Excellence in Emergency Medical Services
4.2.6.51 Masimo Announces Full Market Release of Root® Patient Monitor and Connectivity Hub with Kite™ Supplemental Display System
4.2.6.52 Massena Memorial Hospital of New York Adopts Masimo Root® and Masimo Patient SafetyNet™
4.2.6.53 Masimo Announces CE Marking of Rad-97™Pulse CO-Oximeter® and Connectivity Hub with Noninvasive Blood Pressure
4.2.6.54 New Study Evaluates the Utility of Masimo SpHb® Monitoring During Liver Transplantation
4.2.6.55 Masimo Announces Availability of the RD SedLine® Adult EEG Sensor
4.2.6.56 Masimo Announces Recent Study Monitoring Methemoglobin Levels During Administration of Inhaled Nitric Oxide
4.2.6.57 Masimo Announces CE Marking of Respiration Rate Measurement on MightySat™ Rx
4.2.6.58 Masimo Announces the Addition of Early Warning Score to the Root® Patient Monitoring and Connectivity Platform
4.2.6.59 Masimo Reaffirms Commitment to India with Launch of Advanced Monitoring Technologies Made for India
4.2.6.60 Masimo Announces FDA 510(k) Clearance for TFA-1™ Single-Patient-Use Forehead Sensor
4.2.6.61 Masimo Receives Gates Foundation Grant to Develop Combined Pneumonia-Screening Device for High-Burden Settings
4.2.6.62 Philips and Masimo Sign Multi-Year Business Partnership Agreement in Patient Monitoring and Select Therapy Solutions
4.2.6.63 Adam Mikkelson of Camber Capital Management Joins Masimo’s Board of Directors
4.2.6.64 Study Investigates the Impact of Masimo Continuous SpHb® and PVi® on Anesthesia-related Mortality
4.2.6.65 Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter®
4.2.6.66 Masimo Partners with Smile Train to Advance Safe Surgery
4.2.6.67 Masimo Foundation Co-Founds United for Oxygen Alliance
4.2.6.68 Study on Abdominal Surgical Patients Investigates Clinical Utility of Masimo PVi®
4.2.6.69 New Study Finds Continuous, Noninvasive Hemoglobin Monitoring Using Masimo SpHb® May Reduce Intraoperative Red Blood Cell Transfusion
4.2.6.70 Masimo MightySat™ is Available at Apple.com and Select Apple Retail Stores in the US and Canada
4.2.6.71 Masimo Announces Amendment to Nellcor Royalty Agreement
4.2.6.72 Masimo Announces a Special Worldwide Program for Total Hemoglobin (SpHb®) Monitoring for Areas Affected by the Zika Virus
4.2.6.73 Masimo Announces CE Marking for RAS-45 Sensor for rainbow Acoustic Monitoring® of Respiration Rate
4.2.6.74 New Article Showcases an Effective Surveillance System for General Care Units Using Masimo Patient SafetyNet™
4.2.6.75 Masimo Announces CE Marking for Pediatric O3™ Regional Oximetry
4.2.6.76 Masimo Reports Second Quarter 2016 Financial Results
4.2.6.77 Leading Ohio Critical Access Hospital Adopts Masimo Root® with Radius-7®, Radical-7®, and Patient SafetyNet™ to Create Hospital-Wide Wireless Monitoring and Clinician Notification System
4.2.6.78 New Study Evaluates Masimo PVI® as a Predictor of Fluid Responsiveness in Patients Undergoing Liver Transplantation
4.2.6.79 New Study Assesses Utility of 1st Generation Masimo Pronto® Pulse CO-Oximeter® with SpHb® Spot Check Technology in Evaluating Pediatric Trauma Patients
4.2.6.80 One of the World’s Leading Centers for Cardiovascular Medicine & Transplantation Adopts Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry
4.2.6.81 Masimo Announces FDA 510(k) Clearance for Radius-7® with rainbow® Technology, Including Continuous SpHb®
4.2.6.82 New SunTech Medical CT40 Vital Signs Device to Feature Masimo SET® Pulse Oximetry Technology
4.2.6.83 Masimo Announces 510(k) Clearance for O3™ Regional Oximetry
4.2.6.84 One of India’s Premier Maternal Care Specialists, Motherhood Hospitals, Standardizes on Masimo SET® Technology
4.2.6.85 Masimo Reports First Quarter 2016 Financial Results
4.2.6.86 One of France’s University Hospitals Adopts Masimo Radical-7®, Including SpHb®, PVI®, and SET® Pulse Oximetry
4.2.6.87 New Clinical Study Reports Relationship Between Masimo’s Oxygen Reserve Index (ORI™) and Arterial Partial Pressure of Oxygen During Surgery
4.2.6.88 Masimo Supports Larry Ellison’s Announcement of Indian Wells CEO Raymond Moore’s Resignation
4.2.6.89 New Study Reports on Accuracy of Masimo’s Blue® Sensors at Saturations below 85% in Children with Cyanotic Congenital Heart Disease
4.2.6.90 Masimo Introduces SafetyNet™ Surveillance at HIMSS16
4.2.6.91 Masimo Announces Iris™ Gateway at HIMSS16
4.2.6.92 Masimo Reports Fourth Quarter and Fiscal Year 2015 Financial Results
4.2.6.93 Masimo Announces FDA 510(k) Clearance for Root® with Noninvasive Blood Pressure and Temperature
4.2.6.94 Masimo’s rainbow® Acoustic Monitoring (RAM™) was Associated with Fewer Alarm Events During Planned Moderate Sedation in New Clinical Study
4.2.6.95 In New Clinical Study Masimo’s Oxygen Reserve Index Helps Clinicians Detect Impending Desaturation in Pediatric Patients
4.2.6.96 New Study Shows Utility of Masimo rainbow Acoustic Monitoring™
4.2.6.97 North Carolina’s Appalachian Regional Healthcare System Selects Patient SafetyNet™ and Radius-7™
4.2.6.98 Masimo to Debut Respiration Rate in MightySat™ at Consumer Electronics Show – First Fingertip Pulse Oximeter to Measure Breath Rate
4.2.7 Medtronic
4.2.7.1 Medtronic Announces Paurvi Bhatt as President of Medtronic Foundation
4.2.7.2 Medtronic Clinical Trial to Evaluate ECG Belt for Optimizing Heart Failure Therapy
4.2.7.3 Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
4.2.7.4 Medtronic Launches New Telehealth Solutions in Support of U.S. Department of Veterans Affairs National Contract
4.2.7.5 Medtronic Care Management Services and American Well Announce Strategic Partnership to Integrate Telehealth Capabilities
4.2.7.6 Medtronic and Mercy Announce Data Sharing Partnership to Accelerate Medical Device Innovation
4.2.7.7 Medtronic Completes Sale of a Portion of Its Patient Monitoring & Recovery Division to Cardinal Health
4.2.7.8 Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
4.2.7.9 Medtronic Study Finds High Use of App-Based Remote Cardiac Monitoring Among Older Patients
4.2.7.10 New Study Shows Medtronic Insertable Cardiac Monitors Detect High Rate of Atrial Fibrillation in Previously Undiagnosed High-Risk Patients
4.2.7.11 Medtronic Signs Definitive Agreement to Divest a Portion of Its Patient Monitoring & Recovery Division to Cardinal Health for $6.1 Billion
4.2.7.12 Medtronic Syncs Garmin® Activity Tracker Data Directly into Remote Patient Monitoring Mobile Platform
4.2.7.13 New Guidelines Support Use of Cardiac Monitoring for Patients with Unexplained Fainting
4.2.7.14 New Partnership Between Medtronic and Atlas General Hospital Brings Advanced Surgical Technologies and Treatment Options to Serbia
4.2.7.15 Medtronic Receives FDA Clearance for Reveal LINQ(TM) Insertable Cardiac Monitor (ICM) with TruRhythm(TM) Detection
4.2.7.16 Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
4.2.7.17 Medtronic and Fitbit Partner to Integrate Health and Activity Data Into New CGM Solution for Simplified Type 2 Diabetes Management
4.2.7.18 MiniMed® Connect Mobile Accessory for Android Now Available from Medtronic
4.2.7.19 Medtronic Cardiac Devices Gain FDA Approval to Enable Patient Access to the Most Advanced Diagnostic Imaging
4.2.7.20 Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
4.2.7.21 Medtronic Announces Approval and Launch of Reveal LINQ(TM) Insertable Cardiac Monitor in Japan
4.2.7.22 Medtronic Reports First Quarter Financial Results
4.2.7.23 Medtronic Announces Beacon Heart Failure Management Service, Furthering Its Commitment to Delivering Value in Healthcare
4.2.7.24 Medtronic Outlines Future Growth Vision at Investor Day
4.2.7.25 Medtronic Strengthens Commitment to Asia Pacific
4.2.7.26 Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
4.2.7.27 Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer
4.2.7.28 Medtronic Announces the Pricing Terms of Its Cash Tender Offer of Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.
4.2.7.29 Medtronic Announces the Early Results and Upsizing of Its Cash Tender Offer for Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.
4.2.7.30 Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations
4.2.7.31 Medtronic Announces Cash Tender Offer for Up to $2.75 Billion Aggregate Purchase Price of Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.
4.2.7.32 Medtronic Proposes Proxy Access
4.2.7.33 Medtronic Reports Third Quarter Financial Results
4.2.7.34 Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2016
4.2.8 Mindray Medical
4.2.8.1 Mindray Showcased Star Products at Hospitalar 2018
4.2.8.2 Mindray Showcased New Innovations at CMEF Spring 2018
4.2.8.3 ECR 2018: Envision more with the insightful solution
4.2.8.4 Mindray shined at Arab Health & MEDLAB Dubai 2018
4.2.8.5 Mindray launches BeneVision N1 for uninterrupted monitoring during intra and out-of-hospital patient transport
4.2.8.6 Mindray Showcases Latest Innovation at MEDICA 2017
4.2.8.7 Mindray becomes the first Chinese company to obtain List A CE mark
4.2.8.8 Mindray Showcased Comprehensive Portfolio at Hospitalar 2017
4.2.8.9 Mindray’s Innovations Shined at the 77th CMEF
4.2.8.10 Mindray Shined at ECR 2017 in Vienna
4.2.8.11 Mindray showcased Latest Innovations at Arab Health 2017
4.2.8.12 Mindray Showcases Latest Innovations at MEDICA 2016
4.2.8.13 Notice of ruling in favor of Mindray Medical International Co., Ltd. in its action against Edan Instruments, Inc. on the infringement of intellectual property rights
4.2.8.14 Mindray Release its New Hand-Carried M6 Ultrasound System
4.2.8.15 New Waves in Ultrasound Innovation: Mindray Releases Its Premium Resona 6 Ultrasound System
4.2.8.16 Mindray Releases New Generation DC-40 Ultrasound System
4.2.8.17 Mindray Releases New Generation DC-30 Ultrasound System
4.2.8.18 Mindray officially launched Resona 7 ultrasound system in Europe at ECR 2016
4.2.8.19 Mindray BeneVision N22/N19 Patient Monitor Wins the iF DESIGN AWARD 2016
4.2.9 Natus Medical
4.2.9.1 Natus Medical Announces Second Quarter Financial Results
4.2.9.2 Natus Medical Announces Leadership Changes
4.2.9.3 Natus Confirms Receipt of Notice of Voce Capital’s Intent to Nominate Director Candidates to Replace 50% of the Natus Board
4.2.9.4 Natus Medical Announces Fourth Quarter and Full Year 2017 Financial Results
4.2.9.5 Natus Medical Announces 2018 Annual and First Quarter Financial Guidance
4.2.9.6 Natus Appoints Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit
4.2.9.7 Natus to be Exclusive U.S. Agent for the First Neonatal MRI Device
4.2.9.8 Natus Completes Acquisition of Neurosurgery Assets from Integra LifeSciences
4.2.9.9 Natus Medical Announces Fourth Quarter and Full Year 2016 Financial Results
4.2.9.10 Natus Completes Acquisition of GN Otometrics Business
4.2.9.11 Natus Medical Announces Appointment of Barbara R. Paul, M.D. to its Board of Directors
4.2.9.12 Natus Medical Acquires RetCam Ophthalmic Imaging System
4.2.9.13 Natus Medical Adds to Its Neurodiagnostic Service Market
4.2.9.14 Natus Medical Announces Record Fourth Quarter and Full Year 2015 Financial Results
4.2.9.15 Natus Medical Announces Preliminary Revenue For The First Quarter 2016
4.2.9.16 Natus Medical Announces Record Fourth Quarter And Full Year 2015 Financial Results
4.2.9.17 Natus Medical Announces 2016 Annual And First Quarter Financial Guidance
4.2.10 Nihon Kohden
4.2.10.1 NIHon Kohden Launches Award-Winning Augmented Reality App At HIMSS18
4.2.10.2 Nihon Kohden Launches Aireeg® WEE-1200 Wireless EEG System At HIMSS18
4.2.10.3 Nihon Kohden Launches NK-HIQ™ Wireless Patientmonitoring System At HIMSS18
4.2.10.4 Nihon Kohden Introduces New Bedside Monitor Designed to Meet Precise Needs of Ambulatory Surgery, Specialty Centers
4.2.10.5 Nihon Kohden Expands U.S. Operations with New Pennsylvania Facility
4.2.10.6 Nihon Kohden Awarded New Equipment, Supplies Contract with Premier, Inc.
4.2.10.7 Nihon Kohden Introduces Life Scope G9 Monitor, Designed to be Personalized to Individual Patient Need
4.2.10.8 Nihon Kohden Debuts Breakthrough in Neuromonitoring Remote Access with Live View Panel
4.2.10.9 Nihon Kohden Unveils New Alarm Management and Reporting Software System to Help Hospitals Address Alarm Fatigue
4.2.10.10 Nihon Kohden establishes sales subsidiary in Mexico
4.2.11 Nonin Medical
4.2.11.1 Pulse Oximetry Saturation Values Differ Between Finger, Ear
4.2.11.2 Oximetry You Can Trust: Even in the Most Extreme Environments
4.2.11.3 Nonin Medical Launches Next Generation LifeSense® II and RespSense® II Capnographs

List of Charts
Chart 1 1: Patient Monitoring Equipment Market by Segment, U.S., 2015 – 2025
Chart 1 2: Patient Monitoring Equipment Market Overview, U.S., 2018 & 2025
Chart 2 1: Blood Pressure Monitoring Market by Segment, U.S., 2015 – 2025
Chart 2 2: Blood Pressure Monitoring Market Breakdown, U.S., 2018
Chart 2 3: Blood Pressure Monitoring Market Breakdown, U.S., 2025
Chart 2 4: Total Personal Blood Pressure Monitoring Market by Segment, U.S., 2015 – 2025
Chart 2 5: Total Personal Blood Pressure Monitoring Market, U.S., 2015 – 2025
Chart 2 6: Digital Personal Blood Pressure Monitoring Market, U.S., 2015 – 2025
Chart 2 7: Aneroid Personal Blood Pressure Monitoring Market, U.S., 2015 – 2025
Chart 2 8: Total Professional Blood Pressure Monitoring Market by Segment, U.S., 2015 – 2025
Chart 2 9: Total Professional Blood Pressure Monitoring Market, U.S., 2015 – 2025
Chart 2 10: Digital Professional Blood Pressure Monitoring Market, U.S., 2015 – 2025
Chart 2 11: Aneroid Professional Blood Pressure Monitoring Market, U.S., 2015 – 2025
Chart 2 12: Leading Competitors, Blood Pressure Monitoring Market, U.S., 2018

List of Figures
Figure 1 1: Patient Monitoring Device Market Share Ranking by Segment, U.S., 2018 (1 of 2)
Figure 1 2: Patient Monitoring Device Market Share Ranking by Segment, U.S., 2018 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2018 (1 of 3)
Figure 1 4: Companies Researched in this Report, U.S., 2018 (2 of 3)
Figure 1 5: Companies Researched in this Report, U.S., 2018 (3 of 3)
Figure 1 6: Factors Impacting the Patient Monitoring Equipment Market by Segment, U.S. (1 of 2)
Figure 1 7: Factors Impacting the Patient Monitoring Equipment Market by Segment, U.S. (2 of 2)
Figure 1 8: Recent Events in the Patient Equipment Monitoring Market, U.S., 2015 – 2018 (1 of 3)
Figure 1 9: Recent Events in the Patient Equipment Monitoring Market, U.S., 2015 – 2018 (2 of 3)
Figure 1 10: Recent Events in the Patient Equipment Monitoring Market, U.S., 2015 – 2018 (3 of 3)
Figure 1 11: Patient Monitoring Equipment Markets Covered, U.S., 2018 (1 of 5)
Figure 1 12: Patient Monitoring Equipment Markets Covered, U.S., 2018 (2 of 5)
Figure 1 13: Patient Monitoring Equipment Markets Covered, U.S., 2018 (3 of 5)
Figure 1 14: Patient Monitoring Equipment Markets Covered, U.S., 2018 (4 of 5)
Figure 1 15: Patient Monitoring Equipment Markets Covered, U.S., 2018 (5 of 5)
Figure 1 16: Key Report Updates
Figure 1 17: Version History
Figure 2 1: Blood Pressure Monitoring Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 2 2: Total Personal Blood Pressure Monitoring Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 2 3: Total Personal Blood Pressure Monitoring Market, U.S., 2015 – 2025
Figure 2 4: Digital Personal Blood Pressure Monitoring Market, U.S., 2015 – 2025
Figure 2 5: Aneroid Personal Blood Pressure Monitoring Market, U.S., 2015 – 2025
Figure 2 6: Total Professional Blood Pressure Monitoring Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 2 7: Total Professional Blood Pressure Monitoring Market, U.S., 2015 – 2025
Figure 2 8: Digital Professional Blood Pressure Monitoring Market, U.S., 2015 – 2025
Figure 2 9: Aneroid Professional Blood Pressure Monitoring Market, U.S., 2015 – 2025
Figure 2 10: Drivers and Limiters, Blood Pressure Monitoring Market, U.S., 2018
Figure 2 11: Leading Competitors, Blood Pressure Monitoring Market, U.S., 2018
Figure 4 1: Press Release Summary
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Omron Healthcare
  • Welch Allyn
  • ADC
  • Briggs Healthcare
  • A&D Medical
  • Prestige Medical
  • Graham-Field
  • HoMedics
  • Color Doctor
  • Veridian Healthcare
  • Citizen Systems
  • Labtron
  • McKesson
  • Medline
  • Microlife
  • Panasonic
  • Premier Value
  • Qardio
  • Samsung
  • Spacelabs Healthcare
  • SunTech Medical
  • Utah Medical and WA Baum.
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4756762
Adroll
adroll